Private Trust CO Na Intra Cellular Therapies, Inc. Transaction History
Private Trust CO Na
- $944 Million
- Q4 2024
A detailed history of Private Trust CO Na transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Private Trust CO Na holds 161 shares of ITCI stock, worth $21,195. This represents 0.0% of its overall portfolio holdings.
Number of Shares
161
Previous 161
-0.0%
Holding current value
$21,195
Previous $11,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ITCI
# of Institutions
419Shares Held
88.8MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.28 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$832 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$675 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$428 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$423 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...